Terms: = Liver cancer AND GAS7, O60861, 8522, ENSG00000007237, MGC1348, MLL/GAS7, KIAA0394
6 results:
1. gas7 attenuates hepatocellular carcinoma progression and chemoresistance through the PI3K/Akt signaling pathway.
Liu WF; Zhang QW; Quan B; Zhang F; Li M; Lu SX; Dong L; Yin X; Liu BB
Cell Signal; 2023 Dec; 112():110908. PubMed ID: 37769891
[TBL] [Abstract] [Full Text] [Related]
2. Genomic and transcriptomic profiling reveals key molecules in metastatic potentials and organ-tropisms of hepatocellular carcinoma.
Shi DM; Dong SS; Zhou HX; Song DQ; Wan JL; Wu WZ
Cell Signal; 2023 Apr; 104():110565. PubMed ID: 36539000
[TBL] [Abstract] [Full Text] [Related]
3. Ethnic Differences in cancer Rates Among Adults With Type 2 Diabetes in New Zealand From 1994 to 2018.
Yu D; Wang Z; Cai Y; McBride K; Osuagwu UL; Pickering K; Baker J; Cutfield R; Orr-Walker BJ; Sundborn G; Jameson MB; Zhao Z; Simmons D
JAMA Netw Open; 2022 Feb; 5(2):e2147171. PubMed ID: 35129595
[TBL] [Abstract] [Full Text] [Related]
4. Oxaliplatin inhibits proliferation and migration of human hepatocellular carcinoma cells via gas7C and the N-WASP/FAK/F-actin pathway.
Li D; Zhang B; Hu C
Acta Biochim Biophys Sin (Shanghai); 2017 Jul; 49(7):581-587. PubMed ID: 28475688
[TBL] [Abstract] [Full Text] [Related]
5. New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.
Rambow F; Job B; Petit V; Gesbert F; Delmas V; Seberg H; Meurice G; Van Otterloo E; Dessen P; Robert C; Gautheret D; Cornell RA; Sarasin A; Larue L
Cell Rep; 2015 Oct; 13(4):840-853. PubMed ID: 26489459
[TBL] [Abstract] [Full Text] [Related]
6. Could complement C4 be an alternative to biopsy for chronic hepatitis B histopathologic findings?
Bugdaci MS; Alkim C; Karaca C; Kesici B; Bayraktar B; Sokmen M
J Clin Gastroenterol; 2011; 45(5):449-55. PubMed ID: 21415769
[TBL] [Abstract] [Full Text] [Related]